Biomerica Inc.: The Newport Beach medical diagnostic...
- Share via
Biomerica Inc.: The Newport Beach medical diagnostic kit company posted profit of $33,271, or 1 cent a share, for its fiscal 1995 third quarter, contrasted with a net loss of $54,264, or 1 cent a share, for the corresponding period a year ago. Revenue for the quarter ended Feb. 28 increased 21% to $2.3 million from $1.9 million.
Net income for the nine-month period totaled $65,663, or 2 cents a share, contrasted with a loss of $179,569, or 3 cents a share, for the prior-year period. Sales were up 13% to $6.9 million from $6.1 million.
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.
